Search results
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoThis financial stability is crucial for navigating the capital-intensive pharmaceutical industry and for pursuing strategic acquisitions that can further...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition - KVIA
ABC 7 El Paso· 6 days agoBy MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic. Tuesday ...
Abeona Therapeutics CEO purchases $32,000 in company stock By Investing.com
Investing.com· 7 days agoThe acquisition is a notable investment by the CEO, as it reflects a significant commitment to the...
When judges get free trips to luxury resorts, disclosure is spotty
NPR· 5 days agoFederal judges — occasionally with family members or even their dog in tow — traveled to luxury...
Pig Kidney Transplants Are Medicine’s New Arms Race
Bloomberg· 7 days agoCompanies are vying to end the shortage in donated organs. The real winners will be the patients struggling to get off the wait-list. Lisa Jarvis is a...
3 Surprising Ways to Hedge Against Inflation
Motley Fool via Yahoo Finance· 6 days agoThe last couple of years have been equal parts rewarding and challenging for investors. Inflation has impacted just about every major market sector, and...
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 3 days agoEarnings per share (EPS) was also behind analyst expectations. Looking ahead, revenue is forecast to...
Can journalism survive in the age of AI? An interview with Kara Swisher
TheStreet via Yahoo Finance· 2 days agoJournalist Kara Swisher explains the increasingly challenged relationship between the media and big...
The Bird Flu Outbreak Has More Questions Than Answers
Bloomberg· 5 days agoThe spread of H5N1 at dairy farms keeps surprising scientists. Lisa Jarvis is a Bloomberg Opinion...
Organon First Quarter 2024 Earnings: EPS: US$0.79 (vs US$0.70 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 2 days agoThe company's shares are up 5.7% from a week ago. Risk Analysis What about risks? Every company has...